Related Experiment Video
Updated: Jan 29, 2026

Immunopeptidomics: Isolation of Mouse and Human MHC Class I- and II-Associated Peptides for Mass Spectrometry Analysis
Published on: October 15, 2021
MHC Class II and Beyond: Complex Role of CD74 in Cancer
Joanna Bandola-Simon1, Paul A Roche1
1Experimental Immunology Branch, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892, USA.
Insights
Invariant chain (CD74) is a key regulator of antigen presentation in cancer, influencing immune interactions and therapeutic responses. This review explores CD74
Area of Science:
- Immunology
- Cancer Biology
- Molecular Biology
Background:
- Invariant chain (CD74) is crucial for Major Histocompatibility Complex class II assembly and peptide loading in antigen-presenting cells.
- Emerging research highlights CD74's broader role in cancer, affecting antigen presentation, cytokine signaling, and immune evasion.
- Tumor microenvironments significantly influence CD74 biology and its impact on antitumor immunity.
Purpose of the Study:
- To review and synthesize evidence on CD74's multifaceted role in cancer immunology.
- To explore CD74's function as a "master regulator" of antigen presentation in diverse cancers.
- To examine how CD74 integrates canonical and noncanonical functions in the tumor context.
Main Methods:
- Literature review and synthesis of recent studies on CD74 in cancer.
- Analysis of CD74's involvement in antigen presentation, cytokine signaling, and immune evasion.
- Exploration of CD74's regulatory roles in transcription and signaling pathways.
Main Results:
- CD74 acts as a master regulator of antigen presentation in cancer.
- CD74 integrates chaperone functions with transcriptional regulation and signaling via macrophage migration inhibitory factor.
- Tumor microenvironmental factors modulate CD74's impact on antitumor immunity and treatment outcomes.
Conclusions:
- CD74 plays a pivotal role in shaping the tumor immune microenvironment.
- Understanding CD74's complex biology is essential for developing effective cancer immunotherapies.
- CD74 represents a promising therapeutic target for enhancing antitumor responses.
Abstract:
Invariant chain, also known as CD74 when expressed on the plasma membrane, is classically recognized for its role in Major Histocompatibility Complex class II molecule assembly, trafficking, and peptide loading in professional antigen presenting cells. However, recent studies implicate CD74 as a broader regulator of tumor-immune interactions, modulating antigen presentation, cytokine signaling, and immune evasion across diverse cancers. This review synthesizes emerging evidence that CD74 functions as a "master regulator" of antigen presentation in cancer, integrating its canonical chaperone role with its noncanonical role in transcription regulation and in signaling via macrophage migration inhibitory factor. We explore how tumor microenvironmental contexts redefine CD74 biology, influencing antitumor immunity and therapeutic outcomes.
Related Concept Videos
Drug Classes and Categories
Antibody Structure and Classes
The basic structure of an antibody consists of four protein chains: two identical heavy chains and two identical light chains. These chains are held together by disulfide bonds and other non-covalent interactions, forming a Y-shaped structure.
Antihypertensive Drugs: Thiazide-Class Diuretics
Protein Complex Assembly
Many viruses self-assemble into a fully functional unit using the infected host cell to...
Protein Complexes with Interchangeable Parts
The SCF ubiquitin ligase is a protein complex of five individual proteins. This complex attaches ubiquitin to other target proteins to mark them for degradation. In order...
The Roles of Bacteria and Fungi in Plant Nutrition

